文献速递牙体牙髓病

从临床到炎症介质对牙髓炎症的诊断:一项系统综述

Pulp Inflammation Diagnosis from Clinical to Inflammatory Mediators: A Systematic Review.
PubMed 文献 · J Endod · 2017-05-17

本系统综述检索PubMed和Cochrane数据库1970年至2016年12月发表的研究,分析32篇关于炎症介质表达与临床诊断关系的文献,发现白介素-8、基质金属蛋白酶9、肿瘤坏死因子-α和晚期糖基化终末产物受体在炎症时基因和蛋白水平均升高;临床不可复性牙髓炎与特定炎症介质表达水平相关,可复性与不可复性牙髓炎之间的表达差异既有定量也有定性差异。

要点

  • 白介素-8、基质金属蛋白酶9、肿瘤坏死因子-α和晚期糖基化终末产物受体在炎症时基因和蛋白水平均升高。
  • 临床不可复性牙髓炎与特定炎症介质表达水平相关。
  • 可复性与不可复性牙髓炎之间的炎症介质表达差异既有定量也有定性差异。

核心结论

  • 临床不可复性牙髓炎与特定炎症介质表达水平相关。
  • 可复性与不可复性牙髓炎之间的炎症介质表达差异既有定量也有定性差异。
  • 基于本分析,炎症介质的原位定量可能有助于临床区分可复性与不可复性牙髓炎。

研究设计与样本

  • 系统综述,检索PubMed和Cochrane数据库中1970年至2016年12月发表的文章。
  • 仅纳入已发表的与临床诊断相关的炎症介质表达研究,共分析32篇文章。

主要发现

  • 研究描述了两种分子学方法:蛋白表达分析和基因表达分析。
  • 白介素-8、基质金属蛋白酶9、肿瘤坏死因子-α和晚期糖基化终末产物受体在炎症时基因和蛋白水平均升高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Similar to other tissues, the dental pulp mounts an inflammatory reaction as a way to eliminate pathogens and stimulate repair. Pulp inflammation is prerequisite for dentin pulp complex repair and regeneration; otherwise, chronic disease or pulp necrosis occurs. Evaluation of pulp inflammation severity is necessary to predict the clinical success of maintaining pulp vitality. Clinical limitations to evaluating in situ inflammatory status are well-described. A molecular approach that aids clinical distinction between reversible and irreversible pulpitis could improve the success rate of vital pulp therapy. The aim of this article is to review inflammatory mediator expression in the context of clinical diagnosis. METHODS: We searched PubMed and Cochrane databases for articles published between 1970 and December 2016. Only published studies of inflammatory mediator expression related to clinical diagnosis were eligible for inclusion and analysis. RESULTS: Thirty-two articles were analyzed. Two molecular approaches were described by study methods, protein expression analysis and gene expression analysis. Our review indicates that interleukin-8, matrix metalloproteinase 9, tumor necrosis factor-α, and receptor for advanced glycation end products expression increase at both the gene and protein levels during inflammation. CONCLUSIONS: Clinical irreversible pulpitis is related to specific levels of inflammatory mediator expression. The difference in expression between reversible and irreversible disease is both quantitative and qualitative. On the basis of our analysis, in situ quantification of inflammatory mediators may aid in the clinical distinction between reversible and irreversible pulpitis.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Zanini M, Meyer E, Simon S, et al. Pulp Inflammation Diagnosis from Clinical to Inflammatory Mediators: A Systematic Review. J Endod. 2017. PMID: 28527838. doi:10.1016/j.joen.2017.02.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。